Literature DB >> 23857549

Management of neurogenic orthostatic hypotension in patients with autonomic failure.

Christoph Schroeder1, Jens Jordan, Horacio Kaufmann.   

Abstract

The maintenance of blood pressure in the upright position requires intact autonomic cardiovascular reflexes. Diseases that affect the sympathetic innervation of the cardiovascular system result in a sustained fall in blood pressure upon standing (i.e., neurogenic orthostatic hypotension) that can impair the blood supply to the brain and other organs and cause considerable morbidity and mortality. Here we review treatment options for neurogenic orthostatic hypotension and include an algorithm for its management that emphasizes the importance of non-pharmacologic measures and provides guidance on pharmacologic treatment options.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23857549     DOI: 10.1007/s40265-013-0097-0

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  133 in total

1.  [Therapy of orthostatic disorders of cardiovascular regulation. Placebo controlled double-blind study with oxilofrine].

Authors:  K Pohl; W Kriech
Journal:  Fortschr Med       Date:  1991-11-20

2.  Sodium paradoxically reduces the gastropressor response in patients with orthostatic hypotension.

Authors:  Satish R Raj; Italo Biaggioni; Bonnie K Black; Aniket Rali; Jens Jordan; Indu Taneja; Paul A Harris; David Robertson
Journal:  Hypertension       Date:  2006-06-19       Impact factor: 10.190

3.  Prevalence of orthostatic hypotension in Parkinson's disease.

Authors:  J M Senard; S Raï; M Lapeyre-Mestre; C Brefel; O Rascol; A Rascol; J L Montastruc
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-11       Impact factor: 10.154

4.  Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension.

Authors:  F M Fouad-Tarazi; M Okabe; H Goren
Journal:  Am J Med       Date:  1995-12       Impact factor: 4.965

5.  [Orthostatic hypotension in the aged].

Authors:  E Lang
Journal:  Cardiology       Date:  1976       Impact factor: 1.869

6.  Norepinephrine precursor therapy in neurogenic orthostatic hypotension.

Authors:  Horacio Kaufmann; Daniela Saadia; Andrei Voustianiouk; David S Goldstein; Courtney Holmes; Melvin D Yahr; Rachel Nardin; Roy Freeman
Journal:  Circulation       Date:  2003-07-28       Impact factor: 29.690

7.  Observations on haematological and cardiovascular effects of erythropoietin treatment in multiple system atrophy with sympathetic failure.

Authors:  Andrea Sylvia Winkler; Sabine Landau; Peter Watkins; K Ray Chaudhuri
Journal:  Clin Auton Res       Date:  2002-06       Impact factor: 4.435

8.  Orthostatic hypotension as a manifestation of vitamin B12 deficiency.

Authors:  Leila Ganjehei; Ali Massumi; Mehdi Razavi; James M Wilson
Journal:  Tex Heart Inst J       Date:  2012

9.  Role of physical countermaneuvers in the management of orthostatic hypotension: efficacy and biofeedback augmentation.

Authors:  C M Bouvette; B R McPhee; T L Opfer-Gehrking; P A Low
Journal:  Mayo Clin Proc       Date:  1996-09       Impact factor: 7.616

10.  Treatment of idiopathic orthostatic hypotension (Shy-Drager syndrome) with indomethacin.

Authors:  M S Kochar; H D Itskovitz
Journal:  Lancet       Date:  1978-05-13       Impact factor: 79.321

View more
  11 in total

1.  Orthostatic hypotension leading to recurrent syncope episodes in a hypertensive patient: Treatment with Tianma Gouteng Decoction.

Authors:  Yun-fei Wang; La Zhang
Journal:  Chin J Integr Med       Date:  2013-10-30       Impact factor: 1.978

2.  Multiple system atrophy: using clinical pharmacology to reveal pathophysiology.

Authors:  Jens Jordan; Cyndya Shibao; Italo Biaggioni
Journal:  Clin Auton Res       Date:  2015-03-11       Impact factor: 4.435

Review 3.  Droxidopa: a review of its use in symptomatic neurogenic orthostatic hypotension.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2015-02       Impact factor: 9.546

4.  Droxidopa in neurogenic orthostatic hypotension.

Authors:  Horacio Kaufmann; Lucy Norcliffe-Kaufmann; Jose-Alberto Palma
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-06-19

Review 5.  Syncope and Headache.

Authors:  Ramesh K Khurana
Journal:  Curr Pain Headache Rep       Date:  2018-06-15

6.  Supine hypertension in Parkinson's disease and multiple system atrophy.

Authors:  Alessandra Fanciulli; Georg Göbel; Jean Pierre Ndayisaba; Roberta Granata; Susanne Duerr; Stefano Strano; Carlo Colosimo; Werner Poewe; Francesco E Pontieri; Gregor K Wenning
Journal:  Clin Auton Res       Date:  2016-01-22       Impact factor: 4.435

Review 7.  Pure Autonomic Failure.

Authors:  Pariwat Thaisetthawatkul
Journal:  Curr Neurol Neurosci Rep       Date:  2016-08       Impact factor: 5.081

Review 8.  Evaluating the effectiveness of atomoxetine for the treatment of primary orthostatic hypotension in adults.

Authors:  Hetal Patel; Ashley Simpson; Gabrielle Palevoda; Genevieve M Hale
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-22       Impact factor: 3.738

9.  Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension.

Authors:  Jung-Ick Byun; Do-Yong Kim; Jangsup Moon; Hye-Rim Shin; Jun-Sang Sunwoo; Woo-Jin Lee; Han-Sang Lee; Kyung-Il Park; Soon-Tae Lee; Keun-Hwa Jung; Ki-Young Jung; Manho Kim; Sang Kun Lee; Kon Chu
Journal:  Ann Clin Transl Neurol       Date:  2019-12-19       Impact factor: 4.511

Review 10.  New developments in the management of neurogenic orthostatic hypotension.

Authors:  Italo Biaggioni
Journal:  Curr Cardiol Rep       Date:  2014-11       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.